Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
07/2008
07/30/2008CN101230098A Streptococcus pneumoniae proteins and nucleic acid molecules
07/30/2008CN101230096A Peptide derived from hepatitis C virus
07/30/2008CN100406891C 利用EPF受体鉴定结合或调节hDRR活性的化合物以及hDRR的分离 Identification of isolated compounds utilizing EPF receptor binding or regulate the activity and hDRR of hDRR
07/30/2008CN100406577C Method for identifying soybean seed authenticity and/or purity of variety
07/30/2008CN100406576C Chip copying method for DNA computation
07/30/2008CN100406575C Method for preparing positive control for single-tube RT-PCR detection of three fish disease virus
07/30/2008CN100406574C Identification of kelp gametocyte with different behaviors and acceptable partial DNA sequence
07/30/2008CN100406573C Method for economic alginate laver idioplasm resource identification and partial DNA sequence
07/30/2008CN100406572C Genetic test for the identification of carriers of complex vertebral malformations in cattle
07/30/2008CN100406571C Selecting animals for parentally imprinted traits
07/30/2008CN100406570C Sgk and Nedd used as diagnostic and therapeutic targets
07/30/2008CN100406569C Methods and kits for identifing scavengers of reactive oxygen species (Ros)
07/30/2008CN100406470C Protein for causing sperm not wandering prepared from india worm lizard body cavity liquid
07/30/2008CN100406469C Novel protein, gene encoding the same and method of utilization thereof
07/30/2008CA2619799A1 Methods for evaluating and implementing prostate disease treatments
07/29/2008US7406385 System and method for consensus-calling with per-base quality values for sample assemblies
07/29/2008US7405290 A gene (designated 161P2F10B) and its encoded protein which exhibits tissue specific expression in normal adult tissue and is aberrantly expressed in the cancers; medical diagnostis;, prognosis, prophylactis and/or gene therapy; tissue-target therapy; used to elicit a humoral or cellular immune response
07/29/2008US7405289 Polynucleotide encoding polypeptide comprising proline/glutamine rich domain, an RFX DNA binding domain, an RFX B domain, an RFX C domain, a dimerization domain and a serine/threonine domain; drug screening ; gene therapy; promote differentiations into functioning beta-cells(insulin); diabetes diagnosis
07/29/2008US7405288 V-like domain binding molecules and polynucleotides encoding therefor
07/29/2008US7405283 Using defects in base excision repair and glycosylase activity as diagnostic indicators of cell proliferative disorders of bowels
07/29/2008US7405281 Fluorescent nucleotide analogs and uses therefor
07/29/2008US7405280 assaying the activity of TAFI (Thrombin Activatable Fibrinolysis inhibitor) in a blood sample; e.g. 3-chloro-p-tolylazoformylphenylalanylarginine
07/29/2008US7405272 Selectin ligand interactor cytoplasmic (SLIC-1), a P-selectin glycoprotein ligand (PSGL-1) binding protein
07/29/2008US7405205 Antitumor antisense sequences directed against R1 and R2 components of ribonucleotide reductase
07/29/2008US7405192 Difference between the amplified sequence and the normal gene sequence is diagnostic of glaucoma
07/29/2008US7405081 Identifying free radical scavenger for preventing nucleotide and proteins sequence damages
07/29/2008US7405077 Sperm protein 17 for the diagnosis and treatment of cancer
07/29/2008US7405073 Point source biological agent detection system
07/29/2008US7405062 using non-PCR (polymerase chain reaction) process (DNA-dependent RNA polymerase driven RNA transcription-based, strand displacement, rolling circle, and ramification amplification; ligase chain reaction; for protein libraries
07/29/2008US7405059 Modified Shine-Dalgarno sequences and methods of uses thereof
07/29/2008US7405051 Method of screening antiplatelet agents
07/29/2008US7405046 Compositions and methods for treatment of rhinovirus
07/29/2008US7405045 Retrieving ductal fluid samples from ducts using elongated lumen and detecting presence of papilloma, Epstein-barr and herpes virus
07/29/2008US7405044 Multiplex PCR for simultaneous quantitation of human nuclear, mitochondrial, and male Y-chromosome DNA
07/29/2008US7405043 Responsiveness to therapy for liver disorders
07/29/2008US7405042 Method of extracting nucleic acid or protein using dendrimers and dendrimer-compositional substances
07/29/2008US7405041 Methods for regulating transcription by targeting quadruplex DNA
07/29/2008US7405040 Preamplification of Dna; fluorescence labels; polymerase chain reaction
07/29/2008US7405039 Hepatitis B virus (HBV) variant with reduced sensitivity to entecavir (ETV) and/or lamivudine (LMV) for use as tool in screening viricidal agents and therapeutic protocols which prevent infection, replication and/or release of viral particles
07/29/2008US7405038 Baculovirus expressing recombinant protein with gene inhibiting apoptosis
07/29/2008US7405037 Methods and tools for detecting collagen degradation
07/29/2008US7404977 An isolated aspartic protease of Eurotiomycetes, and used in both milk clotting and cheese preparation; screening amino acid sequences for the presence of Phe-Asp-Tyr-Gly-Ser-Ser-Asp or Phe-Asp-Tyr-Gly-Ser-Ser-Glu
07/29/2008US7404945 Method of evaluating pharmacological effects of medicine
07/29/2008US7404912 Salicylamide-lanthanide complexes for use as luminescent markers
07/29/2008CA2413670C Human brain and testis-specific immunoglobulin superfamily (bt-igsf) cdna for diagnosis of aplasia of corpus callosum and aspermatogenesis
07/29/2008CA2375383C Modulators of methylation for control of bacterial virulence
07/29/2008CA2373680C Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
07/29/2008CA2307002C Antitumour uridine analogues
07/29/2008CA2296144C Oligonucleotide primers for efficient detection of hepatitis c virus (hcv) and methods of use thereof
07/29/2008CA2291685C Pharmaceutical product for the detection of helicobacter pylori-induced gastrointestinal disorder
07/29/2008CA2285922C Methods of diagnosing clinical subtypes of crohn's disease with characteristic responsiveness to anti-th1 cytokine therapy
07/29/2008CA2268771C Polymorphisms and new genes in the region of the human hemochromatosis gene
07/29/2008CA2250141C Monoclonal antibodies specific for the extracellular domain of prostate specific membrane antigen
07/29/2008CA2209080C Fluorometric assay for detecting nucleic acid cleavage
07/29/2008CA2160121C T cell epitopes of the major allergens from dermatophagoides (house dust mite)
07/29/2008CA2147593C Dual purpose tissue fixative
07/29/2008CA2088652C Improved oxidative coupling dye for spectrophotometric quantitative analysis of analytes
07/25/2008CA2616426A1 Enhancement of vanadium-containing phosphatase inhibitors
07/24/2008WO2008089465A2 Gene polymorphisms as sex-specific predictors in cancer therapy
07/24/2008WO2008089438A2 A membrane receptor for retinol binding protein mediates cellular uptake of vitamin a, methods of use and compositions
07/24/2008WO2008089397A2 Adrb2 cancer markers
07/24/2008WO2008089286A1 Stable reagents and kits useful in loop-mediated isothermal amplification (lamp)
07/24/2008WO2008089282A2 Sensors for detecting subtances indicative of stroke, ischemia, infection or inflammation
07/24/2008WO2008089275A2 Particle matrix for storage of biomolecules
07/24/2008WO2008089274A2 Tumor repressor genes in the prevention of cancer
07/24/2008WO2008089236A2 Compositions and methods for diagnosing, treating, and preventing prostate conditions
07/24/2008WO2008089123A2 Methods for analysis of hedgehog pathway inhibitors
07/24/2008WO2008089108A2 Sire early selection for male fertility using single nucleotide polymorphisms (snps) of the dazl gene
07/24/2008WO2008089035A1 Genetic variations associated with tumors
07/24/2008WO2008088893A2 Gene polymorphisms in vegf and vegf receptor 2 as markers for cancer therapy
07/24/2008WO2008088885A2 Epidermal growth factor receptor mutations and methods of use
07/24/2008WO2008088861A2 Gene polymorphisms predictive for dual tki therapy
07/24/2008WO2008088855A2 Gene polymorphisms as predictors of tumor progression and their use in cancer therapy
07/24/2008WO2008088854A2 Genetic markers for predicting responsiveness to combination therapy
07/24/2008WO2008088804A1 Genetic analyses predictive of asthma
07/24/2008WO2008088747A2 Method of monitoring hiv infection
07/24/2008WO2008088524A2 Thrombospondin-domain-deficient r-spondin 1 protein as gastrointestinal tract epithelial proliferation factor
07/24/2008WO2008088357A1 Ultrasensitive amperometric saliva glucose sensor strip
07/24/2008WO2008088322A2 Smart microarray cancer detection system
07/24/2008WO2008088236A1 Method for genetically identifying a person according to the analysis of the single nucleotide polymorphism of a human genom by means of a oligonucleotide biological microchip (biochip)
07/24/2008WO2008088046A1 Novel glycosyltransferase and polynucleotide encoding the same
07/24/2008WO2008087896A1 Method for determination of low-density lipoprotein cholesterol, and reagent for the method
07/24/2008WO2008087895A1 Method for determination of high-density lipoprotein cholesterol, and reagent for the method
07/24/2008WO2008087419A2 Animal model for adhd
07/24/2008WO2008087407A1 Sensor for spores
07/24/2008WO2008087256A1 Method for modifying cells
07/24/2008WO2008087209A1 Human diabetes susceptibility iglc gene
07/24/2008WO2008087208A2 Maize plants characterised by quantitative trait loci (qtl)
07/24/2008WO2008087205A1 Human diabetes susceptibility sema6d gene
07/24/2008WO2008087204A1 Human diabetes susceptibility btbd9 gene
07/24/2008WO2008087049A1 Diagnostic marker and platform for drug design in myocardial infarction and heart failure
07/24/2008WO2008087040A2 Methods and nucleic acids for analyses of cell proliferative disorders
07/24/2008WO2008087038A2 Diagnosis and therapy of diseases relating to a disproportion of luteinizing hormone/chorionic gonadotropin receptor (lhr; lhcgr) splice variants
07/24/2008WO2008087035A2 Screening method for anti-diabetic compounds
07/24/2008WO2008086830A1 Method for detecting the presence of pathogens, and especially human papillomavirus (hpv), in a cervicovaginal sample
07/24/2008WO2008086800A2 Predisposition to, prognosis for and treatment of breast cancer relating to human chromosome 16
07/24/2008WO2008086799A1 Predisposition to, prognosis for and treatment of breast cancer relating to human chromosome 1 (presence)
07/24/2008WO2008086645A1 Method for screening agent with angiogenic-modulating activities using teleost embryo
07/24/2008WO2008086579A1 Diagnostic methods and agents
07/24/2008WO2008069747A3 Woody plants having improved growth characteristics and method for making the same